ALLMedicine™ Breast Cancer Screening Center
Research & Reviews 2,017 results
https://doi.org/10.1148/rg.220155
Radiographics : a Review Publication of the Radiological ... Gao Y, Perez CA et. al.
Mar 18th, 2023 - Women who survived childhood cancers or cancers at a young age are at high risk for breast cancer later in life. The accentuated risk is notable among those treated at a young age with a high radiation dose but also extends to survivors treated wi...
https://doi.org/10.1016/j.jacr.2022.12.014
Journal of the American College of Radiology : JACR; Grimm LJ
Mar 16th, 2023 - Triaging Patient Scheduling Can Minimize the Risks of Breast Cancer Screening Programs.|2023|Grimm LJ,|
https://doi.org/10.1097/NCC.0000000000001229
Cancer Nursing; Ozcelik H, Gozum S
Mar 14th, 2023 - First-degree biological relatives of individuals with breast cancer have a higher risk of breast cancer. The purpose of this study was to create a protocol for evaluating the effect of the Breast Cancer Risk Reduction Program (BrCaRRP) on the part...
https://doi.org/10.1001/jamanetworkopen.2023.2420
JAMA Network Open; Tran TXM, Chang Y et. al.
Mar 11th, 2023 - Evidence suggests that women with a family history of breast cancer (FHBC) in first-degree relatives have a higher level of breast density; however, studies of premenopausal women remain limited. To investigate the association between FHBC and mam...
https://clinicaltrials.gov/ct2/show/NCT05755269
Mar 6th, 2023 - PRIMARY OBJECTIVES: I. To explore if the addition of an individual polygenic risk score (PRS) to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will improve intentions to adhere to recommended breast cancer screening s...
Guidelines 14 results
https://doi.org/10.1016/j.jacr.2021.09.005
Journal of the American College of Radiology : JACR; , Brown A et. al.
Nov 20th, 2021 - Breast cancer screening recommendations for transgender and gender nonconforming individuals are based on the sex assigned at birth, risk factors, and use of exogenous hormones. Insufficient evidence exists to determine whether transgender people ...
https://doi.org/10.1016/j.jacr.2021.09.002
Journal of the American College of Radiology : JACR; , Weinstein SP et. al.
Nov 20th, 2021 - Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be consid...
https://doi.org/10.7326/M19-2125
Annals of Internal Medicine; Schünemann HJ, Lerda D et. al.
Nov 26th, 2019 - The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health ...
https://doi.org/10.7326/M18-2147
Annals of Internal Medicine; Qaseem A, Lin JS et. al.
Apr 9th, 2019 - The purpose of this guidance statement is to provide advice to clinicians on breast cancer screening in average-risk women based on a review of existing guidelines and the evidence they include. This guidance statement is derived from an appraisal...
https://doi.org/10.6004/jnccn.2018.0083
Journal of the National Comprehensive Cancer Network : JN... Bevers TB, Helvie M et. al.
Nov 18th, 2018 - The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected breast cancer due to either abnormal imagin...
Drugs 5 results see all →
Clinicaltrials.gov 177 results
https://clinicaltrials.gov/ct2/show/NCT05755269
Mar 6th, 2023 - PRIMARY OBJECTIVES: I. To explore if the addition of an individual polygenic risk score (PRS) to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will improve intentions to adhere to recommended breast cancer screening s...
https://clinicaltrials.gov/ct2/show/NCT05395871
Mar 3rd, 2023 - This study will be conducted as a randomised control trial in the London screening region of the National Health Service Breast Screening Programme. The study will last over 6 months. The administrative hub for the National Health Service Breast S...
https://clinicaltrials.gov/ct2/show/NCT05286749
Feb 28th, 2023 - The effectiveness of offering self-collection sampling options to Southeast Asian refugee and immigrant populations to improve cervical cancer screening participation has not been investigated. The Milwaukee Consortium for Hmong Health (MCHH), sup...
https://clinicaltrials.gov/ct2/show/NCT05731453
Feb 17th, 2023 - The study will recruit women age 40-50 referred for clinical mammography at the Vestre Viken Breast Center, with mammographic density BI-RADS a or d. After informed consent, saliva from the participants will be sampled and tested for polygenetic r...
https://clinicaltrials.gov/ct2/show/NCT05723237
Feb 10th, 2023 - Breast cancer is a disease that occurs with the uncontrolled proliferation of cells surrounding the milk glands and ducts in the breast (WHO, 2018). According to the 2020 data of the International Agency for Research on Cancer (IARC) Global Cancer...
News 488 results
https://www.mdedge.com/hematology-oncology/article/261443/breast-cancer/meta-analysis-shows-mri-most-effective-supplemental
Feb 24th, 2023 - Key clinical point: Magnetic resonance imaging (MRI) proved to be the best supplemental breast cancer (BC) screening modality in women with dense breasts and who had a negative mammogram who were at an average or intermediate risk for the disease.
https://www.mdedge.com/obgyn/article/261310/breast-cancer/progress-breast-cancer-screening-over-past-50-years-remarkable
Mark D. Pearlman, MD
Feb 19th, 2023 - Meaningful progress has been made in reducing deaths due to breast cancer over the last half century, with a 43% decrease in mortality rate (breast cancer deaths per 100,000 population). 1 Screening mammography (SM) has contributed greatly to that.
https://www.mdedge.com/hematology-oncology/article/260839/breast-cancer/microcalcifications-and-high-breast-density
Jan 26th, 2023 - Key clinical point: Microcalcifications and breast density, as assessed by the Breast Imaging Reporting and Data System 4th edition (BI-RADS) were associated with a significantly increased risk for breast cancer (BC). Major finding: Microcalcifica.
https://www.mdedge.com/familymedicine/article/260820/preventive-care/shared-decision-making-when-youre-wearing-paper-gown
MDedge Family Medicine; Kate Rowland, MD, MS, FAAFP
Jan 26th, 2023 - I offer screening mammograms to my patients starting at age 40. I have developed a little script to explain that I recommend them routinely by age 50, but at younger ages, individual decision-making is required because the science to support breas.
https://www.mdedge.com/familymedicine/article/260818/preventive-care/how-integrate-shared-decision-making-your-practice
MDedge Family Medicine; Matthew Brian Mackwood, MD, MPH, Inger Imset, BA, NBCHWC et. al.
Jan 26th, 2023 - Shared decision-making (SDM), a methodology for improving patient communication, education, and outcomes in preference-sensitive health care decisions, debuted in 1989 with the Ottawa Decision Support Framework1 and the creation of the Foundation.